Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.

PubWeight™: 2.30‹?› | Rank: Top 2%

🔗 View Article (PMC 1430317)

Published in Mol Cell Biol on April 01, 2006

Authors

Hung-Hsi Chen1, Yu-Chiuan Wang, Ming-Ji Fann

Author Affiliations

1: Institute of Neuroscience, National Yang-Ming University, Taipei 11221, Taiwan, Republic of China.

Articles citing this

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25

CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev (2010) 2.52

The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev (2011) 2.24

Cyclin-dependent kinases: a family portrait. Nat Cell Biol (2009) 1.80

A partial form of recessive STAT1 deficiency in humans. J Clin Invest (2009) 1.59

Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II. Mol Cell Biol (2012) 1.08

Updating the CTD Story: From Tail to Epic. Genet Res Int (2011) 1.06

Cyclin K goes with Cdk12 and Cdk13. Cell Div (2012) 1.03

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene (2015) 1.00

Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing. Mol Cell Biol (2015) 1.00

CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing. J Virol (2008) 0.99

Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. Cancers (Basel) (2015) 0.99

A functional screen reveals an extensive layer of transcriptional and splicing control underlying RAS/MAPK signaling in Drosophila. PLoS Biol (2014) 0.95

Control of alternative pre-mRNA splicing by Ca(++) signals. Biochim Biophys Acta (2008) 0.95

Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing. Nat Genet (2016) 0.88

Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex. Nucleic Acids Res (2015) 0.88

Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration. Mol Cell Proteomics (2014) 0.87

CYCLIN-DEPENDENT KINASE G1 is associated with the spliceosome to regulate CALLOSE SYNTHASE5 splicing and pollen wall formation in Arabidopsis. Plant Cell (2013) 0.85

The cyclin K/Cdk12 complex: an emerging new player in the maintenance of genome stability. Cell Cycle (2012) 0.84

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors. Nat Chem Biol (2016) 0.83

Ectopic expression of nolz-1 in neural progenitors promotes cell cycle exit/premature neuronal differentiation accompanying with abnormal apoptosis in the developing mouse telencephalon. PLoS One (2013) 0.83

Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease. Cell Mol Biol Lett (2011) 0.82

TFIP11, CCNL1 and EWSR1 Protein-protein Interactions, and Their Nuclear Localization. Int J Mol Sci (2008) 0.80

The RNA binding motif protein 15B (RBM15B/OTT3) is a functional competitor of serine-arginine (SR) proteins and antagonizes the positive effect of the CDK11p110-cyclin L2α complex on splicing. J Biol Chem (2010) 0.78

GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration. Oncotarget (2016) 0.77

Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding. Sci Rep (2015) 0.77

Cross-talk of phosphorylation and prolyl isomerization of the C-terminal domain of RNA Polymerase II. Molecules (2014) 0.76

Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes. Biomed Rep (2016) 0.75

Cdk12 is essential for embryonic development and the maintenance of genomic stability. Cell Death Differ (2015) 0.75

The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1. BMC Cell Biol (2017) 0.75

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

Finishing the euchromatic sequence of the human genome. Nature (2004) 41.40

Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science (2003) 16.80

The superfamily of arginine/serine-rich splicing factors. RNA (1995) 7.96

Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature (2002) 7.60

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A (2002) 6.84

Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell (2000) 5.16

EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett (2000) 4.96

Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell (2005) 4.91

Alternative splicing in disease and therapy. Nat Biotechnol (2004) 4.85

Aberrant and alternative splicing in cancer. Cancer Res (2004) 4.67

Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol (1997) 3.95

Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J (1995) 3.56

Cell signalling and the control of pre-mRNA splicing. Nat Rev Mol Cell Biol (2004) 2.78

Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA (1995) 2.60

Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron (2001) 1.93

Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol Cell Biol (1996) 1.90

Can sequencing shed light on cell cycling? Nature (2001) 1.85

The concentration of retinoic acid determines the differentiated cell types formed by a teratocarcinoma cell line. Dev Biol (1983) 1.64

SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res (1998) 1.63

RNA processing and human disease. Cell Mol Life Sci (2000) 1.52

The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn). Mol Biol Cell (1999) 1.46

CDK11 complexes promote pre-mRNA splicing. J Biol Chem (2002) 1.33

Role of CDK/cyclin complexes in transcription and RNA splicing. Cell Signal (2005) 1.32

CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. J Cell Sci (2001) 1.26

The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. J Cell Sci (1998) 1.24

Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J Biol Chem (2003) 1.23

Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells. J Biol Chem (2003) 1.17

Cyclin L is an RS domain protein involved in pre-mRNA splicing. J Biol Chem (2002) 1.17

Role of SR protein modular domains in alternative splicing specificity in vivo. Nucleic Acids Res (2000) 1.05

A new subfamily of high molecular mass CDC2-related kinases with PITAI/VRE motifs. Biochem Biophys Res Commun (2000) 0.98

Differential expression of protein kinases in cultured primary neurons derived from the cerebral cortex, hippocampus, and sympathetic ganglia. J Biomed Sci (1998) 0.83

Articles by these authors

Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene (2003) 1.36

Identification of a developmentally regulated striatum-enriched zinc-finger gene, Nolz-1, in the mammalian brain. Proc Natl Acad Sci U S A (2004) 1.34

CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochem Biophys Res Commun (2007) 1.20

Protogenin defines a transition stage during embryonic neurogenesis and prevents precocious neuronal differentiation. J Neurosci (2010) 0.95

The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis. Biochem J (2004) 0.88

OPA1 expression in the human retina and optic nerve. Exp Eye Res (2006) 0.87

Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. J Biol Chem (2010) 0.82

Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes. J Pathol (2002) 0.81

Induction of vitronectin and integrin alphav in the retina after optic nerve injury. Mol Vis (2006) 0.80

Characterization of Ca2+ signaling pathways in mouse adrenal medullary chromaffin cells. J Neurochem (2009) 0.79

Glycogen phosphorylase in glycogen-rich cells is involved in the energy supply for ion regulation in fish gill epithelia. Am J Physiol Regul Integr Comp Physiol (2007) 0.79

Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans. Antimicrob Agents Chemother (2005) 0.78

Novel mutations of the OPA1 gene in Chinese dominant optic atrophy. Ophthalmology (2009) 0.78

Change of gene expression profiles in the retina following optic nerve injury. Brain Res Mol Brain Res (2002) 0.77

Up-regulation of cytochrome oxidase in the retina following optic nerve injury. Exp Eye Res (2002) 0.75

A novel exon 15-deleted, splicing variant of Slit2 shows potential for growth inhibition in addition to invasion inhibition in lung cancer. Cancer (2011) 0.75